Come up with a name for your new list and we'll add to it:
Adgero Biopharmaceuticals Holdings raised a round of funding on February 22, 2017. Investors include
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co..
Adgero Biopharmaceuticals Holdings is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) product with b…